Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | H3SG9 | — |
Expired dose administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a patient who received HAB (Twinrix) (batch number H3SG9, expiry date 03-JAN-2025) for prophylaxis. On 10-FEB-2025, the patient received the 1st dose of Twinrix. On 10-FEB-2025, an unknown time after receiving Twinrix, the patient experienced expired vaccine used (Verbatim: Expired dose administered). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-FEB-2025 Registered nurse reported that a dose of Twinrix was administered on 10 February 2025, but then they noticed it had an expiration date of 03 January 2025 which led to expired vaccine used. No prior Hepatitis A or Hepatitis B vaccines were administered so far. Any patient demographics were not provided. The Vaccine Administration Facility is the same as Primary Reporter. Consented to follow up.